INOVIO PHARMACEUTICALS, INC. Banking Regulation, Total Capital, Actual
INOVIO PHARMACEUTICALS, INC. (INO) had Banking Regulation, Total Capital, Actual of $255.30 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Financial Services
us-gaap:Capital · last filed 2022-11-08
- 2022-09-30: Banking Regulation, Total Capital, Actual $255.30M.
- 2022-06-30: Banking Regulation, Total Capital, Actual $285.10M.
- 2022-03-31: Banking Regulation, Total Capital, Actual $340.50M.
- 2021-09-30: Banking Regulation, Total Capital, Actual $436.00M.
| Period end | Banking Regulation, Total Capital, Actual |
|---|---|
| 2022-09-30 | $255.30M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $285.10M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $340.50M 10-Q · filed 2022-05-10 |
| 2021-09-30 | $436.00M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $490.70M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $546.90M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $335.80M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $344.10M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $243.20M 10-Q · filed 2020-05-11 |
| 2019-09-30 | $79.30M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $86.40M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $107.50M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |